William Blair’s biopharma investment banking team’s Quarterly Rx was cited by the The Wall Street Journal in its coverage of IPO activity and other investment trends in the sector.
Investment Banking
The Wall Street Journal Cites Biopharma Investment Banking’s Quarterly Report
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
-
William Blair Expands Tech Enabled Services Team in Frankfurt With Senior Hire
William Blair announced today the addition of Robert Engelhardt as a director in the firm’s Tech Enabled Services team. Based in Frankfurt, Engelhardt will provide comprehensive advisory resources to companies and financial sponsors throughout the DACH region and across Europe.
-